Ken Griffin ODONATE THERAPEUTICS INC Transaction History

Citadel Advisors LLC

  • $509 Billion
  • Q1 2024

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
N/A
-10,397 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
N/A
-51,968 Reduced 83.33%
10,397 $0
Q3 2021

Nov 15, 2021
SELL
N/A
-110,624 Reduced 63.95%
62,365 $181,000
Q2 2021

Aug 16, 2021
SELL
N/A
-30,475 Reduced 14.98%
172,989 $0
Q1 2021

May 17, 2021
BUY
N/A
126,451 Added 164.19%
203,464 $696,000
Q4 2020

Feb 16, 2021
SELL
N/A
-44,782 Reduced 36.77%
77,013 $1.48 Million
Q3 2020

Nov 16, 2020
BUY
N/A
76,090 Added 166.48%
121,795 $1.64 Million
Q2 2020

Aug 14, 2020
SELL
N/A
-1,730 Reduced 3.65%
45,705 $1.94 Million
Q1 2020

May 15, 2020
BUY
N/A
18,477 Added 63.81%
47,435 $1.31 Million
Q4 2019

Feb 14, 2020
BUY
N/A
17,337 Added 149.19%
28,958 $940,000
Q3 2019

Nov 14, 2019
SELL
N/A
-22,264 Reduced 65.7%
11,621 $0
Q4 2018

Feb 14, 2019
BUY
N/A
33,885 New
33,885 $0
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email